Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats
- 368 Downloads
In metabolic syndrome, the composition of gut microbiota has been disrupted, and is associated with left ventricular (LV) dysfunction. Several types of prebiotics, probiotics, and synbiotics have been shown to exert cardioprotection by restoring gut microbiota from dysbiosis and reducing systemic inflammation. However, the effects of prebiotics such as xylooligosaccharides (XOS); probiotics such as Lactobacillus paracasei STII01 HP4, and synbiotics on metabolic and LV function in obese insulin-resistant rats have not been investigated. In this study, we hypothesized that prebiotics and probiotics improve metabolic parameters, heart rate variability (HRV), blood pressure (BP), and LV function by attenuating cardiac mitochondrial dysfunction, systemic inflammation, and oxidative stress, and that synbiotics provide greater efficacy than a single regimen in obese insulin resistance.
Rats were fed with either normal diet or high-fat diet (HFD) for 12 weeks and then rats in each dietary group were randomly subdivided into four subgroups to receive either a vehicle, prebiotics, probiotics, or synbiotics for another 12 weeks. Metabolic parameters, BP, HRV, LV function, cardiac mitochondrial function, systemic inflammation, and oxidative stress were determined.
HFD-fed rats had obese insulin resistance with markedly increased systemic inflammatory marker [Serum LPS; ND; 0.6 ± 0.1 EU/ml vs. HFD; 5.7 ± 1.2 EU/ml (p < 0.05)], depressed HRV, and increased BP and LV dysfunction [%ejection fraction; ND; 93 ± 2% vs. HFD; 83 ± 2% (p < 0.05)]. Prebiotics, probiotics, and synbiotics attenuated insulin resistance by improving insulin sensitivity and lipid profiles. All interventions also improved HRV, BP, LV function [%ejection fraction; HFV; 81 ± 2% vs. HFPE; 93 ± 3%, HFPO; 92 ± 1%, HFC; 92 ± 2% (p < 0.05)] by attenuating mitochondrial dysfunction, oxidative stress, and systemic inflammation in obese insulin-resistant rats.
Prebiotics, probiotics, and synbiotics shared similar efficacy in reducing insulin resistance and LV dysfunction in obese insulin-resistant rats.
KeywordsPrebiotics Probiotics Synbiotics Obese insulin resistance Cardiac mitochondria Systemic inflammation
This work was supported by Thailand Research Fund Grants RTA (SCC), TRG6080005 (NA), RSA5780029 (AL); a NSTDA Research Chair Grant from the National Science and Technology Development Agency Thailand (NC), and Chiang Mai University Center of Excellence Award (NC). The authors would also like to thank Ms. Gabrielle Metzler for her editorial assistance.
Compliance with ethical standards
Conflicts of interest
The authors declare that there are no conflicts of interest.
- 1.Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH, American Heart A, Obesity Committee of the Council on Nutrition PA, Metabolism (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113(6):898–918CrossRefGoogle Scholar
- 6.Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, Ziegler PK, Varga J, Reindl W, Pommerenke C, Salinas-Riester G, Bock A, Alpert C, Blaut M, Polson SC, Brandl L, Kirchner T, Greten FR, Polson SW, Arkan MC (2014) High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514(7523):508–512CrossRefGoogle Scholar
- 9.Tanajak P, Sa-Nguanmoo P, Wang X, Liang G, Li X, Jiang C, Chattipakorn SC, Chattipakorn N (2016) Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats. Acta Physiol (Oxf) 217(4):287–299CrossRefGoogle Scholar
- 10.Wu CC, Weng WL, Lai WL, Tsai HP, Liu WH, Lee MH, Tsai YC (2015) Effect of Lactobacillus plantarum Strain K21 on High-Fat Diet-Fed Obese Mice. Evid Based Complement Alternat Med 2015:391767Google Scholar
- 12.Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, Sung MK, McGregor RA, Choi MS (2013) Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 8(3):e59470CrossRefGoogle Scholar
- 15.Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110(22):9066–9071CrossRefGoogle Scholar
- 18.Wang HF, Lin PP, Chen CH, Yeh YL, Huang CC, Huang CY, Tsai CC (2015) Effects of lactic acid bacteria on cardiac apoptosis are mediated by activation of the phosphatidylinositol-3 kinase/AKT survival-signalling pathway in rats fed a high-fat diet. Int J Med Sci 35(2):460–470Google Scholar
- 19.Ting WJ, Kuo WW, Kuo CH, Yeh YL, Shen CY, Chen YH, Ho TJ, Viswanadha VP, Chen YH, Huang CY (2015) Supplementary heat-killed Lactobacillus reuteri GMNL-263 ameliorates hyperlipidaemic and cardiac apoptosis in high-fat diet-fed hamsters to maintain cardiovascular function. Br J Nutr 114(5):706–712CrossRefGoogle Scholar
- 21.Imaizumi K, Nakatsu Y, Sato M, Sedarnawati Y, Sugano M (1991) Effects of xylooligosaccharides on blood glucose, serum and liver lipids and cecum short-chain fatty acids in diabetic rats. Agric Biol Chem 55(1):199–205Google Scholar
- 22.Yamamoto S, Pattananandecha T, Sirilun S, Sivamaruthi BS, Peerajan S, Chaiyasut C (2016) Evaluation of cryoprotective potential of Jerusalem artichoke’ inulin during freeze-drying and storage of Lactobacillus paracasei HII01. J Pure Appl Microbiol 10(3):1727–1734Google Scholar
- 33.van den Heuvel JK, Boon MR, van Hengel I, Peschier-van der Put E, van Beek L, van Harmelen V, van Dijk KW, Pereira AM, Hunt H, Belanoff JK, Rensen PC, Meijer OC (2016) Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation. Br J Pharmacol 173(11):1793–1804CrossRefGoogle Scholar
- 39.Lim SM, Jeong JJ, Woo KH, Han MJ, Kim DH (2016) Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutr Res 36(4):337–348CrossRefGoogle Scholar
- 41.Beserra BT, Fernandes R, do Rosario VA, Mocellin MC, Kuntz MG, Trindade EB (2015) A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin Nutr 34(5):845–858CrossRefGoogle Scholar
- 44.Rajpal DK, Klein JL, Mayhew D, Boucheron J, Spivak AT, Kumar V, Ingraham K, Paulik M, Chen L, Van Horn S, Thomas E, Sathe G, Livi GP, Holmes DJ, Brown JR (2015) Selective spectrum antibiotic modulation of the gut microbiome in obesity and diabetes rodent models. PLoS One 10(12):e0145499CrossRefGoogle Scholar
- 45.Delzenne NM, Cani PD, Neyrinck AM (2007) Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr 137(11 Suppl):2547S–2551SGoogle Scholar
- 53.Jackson K, Lovegrove J (2012) Impact of probiotics, prebiotics and synbiotics on lipid metabolism in humans. Nutr Aging 1:181–200Google Scholar
- 61.Sivasinprasasn S, Sa-Nguanmoo P, Pongkan W, Pratchayasakul W, Chattipakorn SC, Chattipakorn N (2016) Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats. Menopause 23(8):894–902CrossRefGoogle Scholar